Related Experiment Video
Updated: Oct 16, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
The mitochondrially-localized nucleoside diphosphate kinase D (NME4) is a novel metastasis suppressor
Marie-Lise Lacombe1, Frederic Lamarche2, Olivier De Wever3
1Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
Background:
Mitochondrial nucleoside diphosphate kinase (NDPK-D, NME4, NM23-H4) is a multifunctional enzyme mainly localized in the intermembrane space, bound to the inner membrane.
Results:
We constructed loss-of-function mutants of NDPK-D, lacking either NDP kinase activity or membrane interaction and expressed mutants or wild-type protein in cancer cells. In a complementary approach, we performed depletion of NDPK-D by RNA interference. Both loss-of-function mutations and NDPK-D depletion promoted epithelial-mesenchymal transition and increased migratory and invasive potential. Immunocompromised mice developed more metastases when injected with cells expressing mutant NDPK-D as compared to wild-type. This metastatic reprogramming is a consequence of mitochondrial alterations, including fragmentation and loss of mitochondria, a metabolic switch from respiration to glycolysis, increased ROS generation, and further metabolic changes in mitochondria, all of which can trigger pro-metastatic protein expression and signaling cascades. In human cancer, NME4 expression is negatively associated with markers of epithelial-mesenchymal transition and tumor aggressiveness and a good prognosis factor for beneficial clinical outcome.
Conclusions:
These data demonstrate NME4 as a novel metastasis suppressor gene, the first localizing to mitochondria, pointing to a role of mitochondria in metastatic dissemination.
Insights
Mitochondrial protein NME4 (NDPK-D) suppresses cancer metastasis. Loss of NME4 function in mitochondria promotes cancer cell invasion and metastasis, highlighting mitochondria
Area of Science:
- Mitochondrial Biology
- Cancer Research
- Metastasis Suppression
Background:
- Mitochondrial nucleoside diphosphate kinase (NDPK-D, also known as NME4 or NM23-H4) is an enzyme primarily located in the mitochondrial intermembrane space.
- Its role in cancer progression and metastasis has not been fully elucidated.
Purpose of the Study:
- To investigate the function of NDPK-D (NME4) in cancer metastasis.
- To determine the impact of mitochondrial alterations on metastatic potential.
Main Methods:
- Construction of loss-of-function mutants for NDPK-D (NME4) affecting kinase activity or membrane interaction.
- Expression of wild-type and mutant NDPK-D in cancer cells, alongside RNA interference-mediated depletion.
- Assessment of cell migration, invasion, and metastasis in immunocompromised mouse models.
Main Results:
- Loss-of-function mutations and depletion of NDPK-D (NME4) induced epithelial-mesenchymal transition, enhancing cell migration and invasion.
- Mice injected with cells expressing mutant NDPK-D exhibited increased metastasis compared to those with wild-type.
- Metastatic reprogramming involved mitochondrial fragmentation, a shift to glycolysis, increased ROS, and altered mitochondrial metabolism, promoting pro-metastatic signaling.
Conclusions:
- NME4 functions as a novel metastasis suppressor gene, uniquely localized to mitochondria.
- Mitochondria play a critical role in regulating metastatic dissemination.
- NME4 expression correlates with reduced epithelial-mesenchymal transition markers and improved clinical outcomes in human cancers.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Inhibition of Cdk Activity
The Nucleolus

